BD has written to users of its Alaris pump modules about a risk associated with two complaints of serious injury. The Food and Drug Administration, which shared details of the letter Friday, has ...

The Food and Drug Administration has posted a Class I notice about Becton Dickinson infusion pumps affected by compatibility issues with Cardinal Health Monoject syringes. Cardinal sent an urgent ...

CareFusion is recalling 7,418 units of its Alaris Syringe infusion pump, a corrective action that the FDA just deemed Class 1. This marks CareFusion's ninth Class 1 recall of an Alaris device since ...

A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.

Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has expanded a Class I Alaris recall to cover 15 ...

The US Food and Drug Administration (FDA) has notified healthcare providers of a class 1 recall of CareFusion's Alaris PC unit (model 8015) with software version 9.12. The Alaris PC unit is the ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. A voluntary safety recall of widely used Alaris infusion ...

The Qualcomm Life Capsule Datacaptor Terminal Server and the Becton Dickinson Alaris TIVA Syringe Pump allow remote access without authentication. Two previously undocumented, critical vulnerabilities ...

FRANKLIN LAKES, N.J., July 18, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls ...